Brian M. Culley - Dec 31, 2021 Form 4 Insider Report for Lineage Cell Therapeutics, Inc. (LCTX)

Role
President and CEO, Director
Signature
/s/ Brian M. Culley
Stock symbol
LCTX
Transactions as of
Dec 31, 2021
Transactions value $
-$13,090
Form type
4
Date filed
1/3/2022, 03:25 PM
Previous filing
Oct 12, 2021
Next filing
Feb 15, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LCTX Common Shares, no par value Options Exercise +15.5K +23.44% 81.4K Dec 31, 2021 Direct F1, F2
transaction LCTX Common Shares, no par value Tax liability -$13.1K -5.34K -6.57% $2.45 76K Dec 31, 2021 Direct F2, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LCTX Restricted Stock Units Options Exercise $0 -15.5K -33.33% $0.00 30.9K Dec 31, 2021 Common Shares 15.5K $0.00 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares earned by the reporting person as a result of the vesting of a portion of restricted stock units ("RSUs") granted to the reporting person on September 17, 2018. Upon settlement, RSUs convert into common shares of the issuer on a one-for-one basis.
F2 Does not include common shares of the issuer that may be acquired upon settlement of RSUs that have not vested as of the date of this filing or upon the exercise of stock options outstanding as of the date of this filing.
F3 Shares withheld by the issuer to satisfy statutory tax withholding requirements on the vesting of 15,450 RSUs in a transaction exempt under Rule 16(b)-3. No shares were sold in connection with this transaction.
F4 The reporting person was granted RSUs on September 17, 2018, that vested with respect to 25% of the shares subject to the award on September 17, 2019, and the balance vest in 12 equal quarterly installments at the end of each quarter thereafter.